Locus Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Locus Biosciences's estimated annual revenue is currently $11.9M per year.
- Locus Biosciences's estimated revenue per employee is $155,000
- Locus Biosciences's total funding is $105M.
Employee Data
- Locus Biosciences has 77 Employees.
- Locus Biosciences grew their employee count by 13% last year.
Locus Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder and CEO | Reveal Email/Phone |
2 | Chief Technology Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Associate VP, Research and Development Program Managment | Reveal Email/Phone |
5 | VP Technology | Reveal Email/Phone |
6 | VP, R&D Program Management | Reveal Email/Phone |
7 | VP Pharmaceutical Operations and Technology | Reveal Email/Phone |
8 | VP, Research and Development | Reveal Email/Phone |
9 | VP Clinical Operations and CMC Operations | Reveal Email/Phone |
10 | Director Automation and Informatics | Reveal Email/Phone |
Locus Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.9M | 77 | 7% | N/A | N/A |
#2 | $6221.7M | 40140 | -4% | N/A | N/A |
#3 | $2M | 13 | 0% | N/A | N/A |
#4 | $0.8M | 5 | -55% | N/A | N/A |
#5 | $2.8M | 18 | 6% | $11.1M | N/A |
#6 | $1M | 13 | -41% | N/A | N/A |
#7 | $1.7M | 11 | 0% | N/A | N/A |
#8 | $0.6M | 4 | 0% | N/A | N/A |
#9 | $5.9M | 38 | -5% | N/A | N/A |
#10 | $6.8M | 44 | 7% | N/A | N/A |
What Is Locus Biosciences?
Locus Biosciences’ novel approach to precision antimicrobials works by taking advantage of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating a small strand of RNA called a CRISPR RNA, which matches a DNA sequence specific to a given invader. If the CRISPR RNA is matched to a complementary DNA sequence, the Cas proteins will cleave the invading DNA.
keywords:N/A$105M
Total Funding
77
Number of Employees
$11.9M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Locus Biosciences News
... Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC and many more.
EpiBiome, a South San Francisco, CA-based precision microbiome engineering company, completed a $6m Series A financing. Backers included Viking Global Investors via the Illumina Accelerator Boost Capital, Matrix Capital Management, Alexandria Venture Investments, SV Tech Ventures and China Rock ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $19.3M | 77 | N/A | N/A |
#2 | $13.9M | 77 | 5% | N/A |
#3 | $12.6M | 81 | 29% | N/A |
#4 | $18M | 82 | -27% | N/A |
#5 | $24.1M | 83 | 24% | N/A |